Ligation or cross-linking of CD40 has different effects on AGS gastric cancer cells

被引:9
作者
Qi, Chun-Jian [1 ,2 ]
Qian, Ke-Qing [1 ]
Ning, Yong-Ling [1 ]
Ma, Hong-Bing [3 ]
Wang, Shi-Zhong [2 ]
Zhang, Xue-Guang [3 ]
机构
[1] Nanjing Med Univ, Dept Oncol, Affiliated Hosp, Changzhou Peoples Hosp 2, Changzhou, Peoples R China
[2] Nanjing Med Univ, Ctr Lab, Affiliated Hosp, Changzhou Peoples Hosp 2, Changzhou, Peoples R China
[3] Soochow Univ, Key Lab Jiangsu Clin Immunol, Suzhou, Peoples R China
关键词
CD40; Gastric cancer; VEGF; Apoptosis; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; LYMPHOMA CELLS; LUNG-CANCER; CLL CELLS; IN-VITRO; EXPRESSION; ACTIVATION; VEGF; ANGIOGENESIS;
D O I
10.1016/j.cellimm.2009.06.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A gastric cancer (GC) cell line, AGS, has high-level expression of CD40, a tumor necrosis factor receptor (TNFR) family member. CD40 is present on the surfaces of a large variety of cells, including B cells, endothelial cells, dendritic cells and some carcinoma cells, and delivers signals regulating diverse cellular responses, such as proliferation, differentiation, growth suppression, and cell death. In this research, we studied the effects of different forms of CD40 stimulation on AGS cells by flow cytometry, Western blotting and siRNA transfection. We found that different forms of CD40 stimulation, either recombinant soluble CD40L (sCD40L, ligation) or agonist anti-CD40 antibody (cross-linking), induced different effects in AGS gastric cancer cells, proliferation or apoptosis. We also showed that VEGF provided a significant contribution to sCD40L-induced proliferation, while agonist anti-CD40 antibody induced GADD45 upregulation and promoted apoptosis. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:135 / 140
页数:6
相关论文
共 34 条
  • [1] Bereznaya N. M., 2008, Experimental Oncology, V30, P295
  • [2] Bereznaya N. M., 2007, Experimental Oncology, V29, P2
  • [3] Internalization of CD40 regulates its signal transduction in vascular endothelial cells
    Chen, Yali
    Chen, Jianjun
    Xiong, Yanbao
    Da, Qi
    Xu, Youli
    Jiang, Xuejun
    Tang, Hong
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (01) : 106 - 117
  • [4] Cooke PW, 1999, J PATHOL, V188, P38
  • [5] D'Orlando O, 2007, J BIOL REG HOMEOS AG, V21, P49
  • [6] CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis
    Deregibus, MC
    Buttiglieri, S
    Russo, S
    Bussolati, B
    Camussi, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) : 18008 - 18014
  • [7] CD60-Induced Signaling in Human Endothelial Cells Results in mTORC2-and Akt-Dependent Expression of Vascular Endothelial Growth Factor InVitro and In Vivo
    Dormond, Olivier
    Contreras, Alan G.
    Meijer, Esther
    Datta, Dipak
    Flynn, Evelyn
    Pal, Soumitro
    Briscoe, David M.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 181 (11) : 8088 - 8095
  • [8] Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells
    Edelmann, J.
    Klein-Hitpass, L.
    Carpinteiro, A.
    Fuehrer, A.
    Sellmann, L.
    Stilgenbauer, S.
    Duehrsen, U.
    Duerig, J.
    [J]. LEUKEMIA RESEARCH, 2008, 32 (10) : 1565 - 1572
  • [9] PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
    Fang, Jing
    Ding, Min
    Yang, Lily
    Liu, Ling-Zhi
    Jiang, Bing-Hua
    [J]. CELLULAR SIGNALLING, 2007, 19 (12) : 2487 - 2497
  • [10] Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells
    Farahani, M
    Treweeke, AT
    Toh, CH
    Till, KJ
    Harris, RJ
    Cawley, JC
    Zuzel, M
    Chen, H
    [J]. LEUKEMIA, 2005, 19 (04) : 524 - 530